Clean Air

@amoberg.bsky.social

😷

Sie nennen es ... 《 Atemwegserkrankung 》🤫 Neurological involvement has been found at different stages of SARS-CoV-2 infection – during acute infection and as post-acute sequelae manifesting in a chronic course of infection 🧪 doi.org/10.1007/s434...

Neurological consequences of COVID-19 - Pharmacological Reports

In December 2019, cases of pneumonia caused by infection with the previously unknown severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to coronavirus disease 2019 (COVID-19), were identified. Typical manifestations of COVID-19 are fever, cough, fatigue and dyspnoea. Initially, it was thought that the mechanism of action of SARS-CoV-2 was only associated with respiratory tract invasion, but it was later revealed that the infection might involve many other organs and systems, including the central and peripheral nervous systems. Neurological complications associated with SARS-CoV-2 infection include encephalopathy, encephalitis, meningitis, acute disseminated encephalomyelitis (ADEM), ischaemic and haemorrhagic stroke and cerebral venous sinus thrombosis. In cases of peripheral nervous system involvement, smell and taste disorders, myopathy or the signs and symptoms of Guillain‒Barré syndrome are observed. The most common early neurological complications, particularly during the first year of the epidemic, were anosmia and taste disorders, which, according to some studies, occurred in over 80 percent of patients with COVID-19. The proportion of patients with serious neurological manifestations was small compared to the global number of patients, but the numbers of SARS-CoV-2 infections and critical patients increased substantially. The experience from 2 years of the pandemic has shown that approximately 13% of infected patients suffer from severe neurological complications. The relationship between SARS-CoV-2 and the nervous system is not only a cause of neurological complications in previously healthy individuals but also directly and indirectly affects the courses of many nervous system diseases.

doi.org

Neurological manifestations can occur during the acute phase as well as in the post-acute phase of the infection Archives of Virology Article: 🧪 SARS-CoV-2 and the nervous system: current perspectives Published: 01 June 2023 Volume 168, article number 171 (2023) link.springer.com/article/10.1...

SARS-CoV-2 and the nervous system: current perspectives - Archives of Virology

SARS-CoV-2 infection frequently causes neurological impairment in both adults and children. Recent publications have described significant aspects of the viral pathophysiology associated with neurolog...

link.springer.com

Die Europäische Kommission ist der Empfehlung der #EMA gefolgt und hat die an #XFG angepassten #Impfstoffe gegen #Covid19 zugelassen. Dazu die Pressemitteilung von #BioNTech: www.biontech.com/de/de/home/m... Es gibt wie erwartet Einzeldosis-Fertigspritzen für Alter: 6M bis 11 Jahre, sowie ab 12 J.

Europäische Kommission genehmigt Marktzulassung des an XFG angepassten COVID-19-Impfstoffs von Pfizer und BioNTech in der Europäischen Union

biontech.com

Dr. McCoy 😷@drmccoy.info · 2w ago

⚠️ Wichtiges Update: Die #CHMP Meeting Highlights der #EMA (vom 20.-23.07.) sind da! Mit guten Nachrichten für alle wichtigen #Impfstoffe mit Anpassung auf #XFG gegen #Covid19 #impfxfg: www.ema.europa.eu/en/news/meet... Alle wurden dieses Mal frühzeitig zur Zulassung empfohlen (Screen + Alt-Text)!⬇️

das, was uns als Corona Erkältung, C-Schnupfen, Atemwegserkrankung verkauft wird heißt Covid-19 ⏬️ SARS-CoV-2 and HSV-1 Induce Amyloid Aggregation in Human CSF @kariemezzat.bsky.social et al. ⤵️ doi: doi.org/10.1101/2022... 🧪 published in ACS Chemical Neuroscience doi: 10.1021/acschemneuro.4c00636

SARS-CoV-2 and HSV-1 Induce Amyloid Aggregation in Human CSF Resulting in Drastic Soluble Protein Depletion

The corona virus (SARS-CoV-2) pandemic and the resulting long-term neurological complications in patients, known as long COVID, have renewed the interest in the correlation between viral infections and neurodegenerative brain disorders. While many viruses can reach the central nervous system (CNS) causing acute or chronic infections (such as herpes simplex virus 1, HSV-1), the lack of a clear mechanistic link between viruses and protein aggregation into amyloids, a characteristic of several neurodegenerative diseases, has rendered such a connection elusive. Recently, we showed that viruses can induce aggregation of purified amyloidogenic proteins via the direct physicochemical mechanism of heterogenous nucleation (HEN). In the current study, we show that the incubation of HSV-1 and SARS-CoV-2 with human cerebrospinal fluid (CSF) leads to the amyloid aggregation of several proteins known to be involved in neurodegenerative diseases, such as: APLP1 (amyloid beta precursor like protein 1), ApoE, clusterin, α2-macroglobulin, PGK-1 (phosphoglycerate kinase 1), ceruloplasmin, nucleolin, 14-3-3, transthyretin and vitronectin. Importantly, UV-inactivation of SARS-CoV-2 does not affect its ability to induce amyloid aggregation, as amyloid formation is dependent on viral surface catalysis via HEN and not its ability to replicate. Additionally, viral amyloid induction led to a dramatic drop in the soluble protein concentration in the CSF. Our results show that viruses can physically induce amyloid aggregation of proteins in human CSF and result in soluble protein depletion, and thus providing a potential mechanism that may account for the association between persistent and latent/reactivating brain infections and neurodegenerative diseases. Significance Statement Viruses have generally been excluded from the etiology of amyloid pathologies based on the assumption that amyloid formation requires a proteinaceous conformational template (a prion) to form. Here we show that neuroinvasive viruses induce amyloid aggregation of a plethora of proteins in human CSF even after UV inactivation. Our work illustrates that viruses can induce amyloid aggregation of endogenous human proteins in their native environment by acting as physical catalysts of amyloid nucleation and phase transition. Demonstrating this direct mechanistic link, which is independent of templating, can help better understand the link between viruses and neurodegenerative disorders, especially in the post-COVID-19 era. ### Competing Interest Statement Competing interests statement: KE, AS, AJE, SA, and TM are cofounders of REGAIN Therapeutics and co-inventors of some of the company's patents.

doi.org

Während der Krieg in der Golfregion tobt, kassieren die großen Ölkonzerne ab: BP, ExxonMobil, Shell und Co. werden laut Oxfam-Studie im zweiten Quartal 2026 zusammen rund 46 Mrd. US-Dollar Nettoprofit einfahren, doppelt so viel wie im Vorquartal. Krisengewinne auf Kosten von #Klima und Gesellschaft!

Studie: Ölkonzerne verdienen Milliarden am Irankrieg

Die größten fossilen Energiekonzerne verdoppeln laut einer Studie der Entwicklungsorganisation Oxfam ihre Profite – und heizen die Klimakrise an.

taz.de

Aus persönlichen Gründen hat er nach 73 Tagen seinen Rücktritt erklärt. Die frei gewordene Stelle wird nun durch drei externe Berater ersetzt. Zusammen kosten sie lediglich sieben Millionen Euro. Sparpolitik kann so überzeugend sein.🙃

Katherina Reiche verliert Chef ihrer Leitungsabteilung ​Die personellen Turbulenzen im Bundeswirtschaftsministerium nehmen kein Ende. Jetzt verliert Ministerin Katherina Reiche nach SPIEGEL-Informationen den Chef ihrer Leitungsabteilung – nur rund zehn Wochen, nachdem er das Amt angetreten hat. ​Von Markus Becker

"One is you have to be very curious about something. No. 2, you have to have an unfailing urge to address the question you have. No. 3, I think it helps to try to combine knowledge in at least two different fields where people don’t necessarily interact.” www.nytimes.com/2026/07/21/s...

Susumu Tonegawa Dies at 86; Nobel Laureate Showed How Antibodies Fight Infection

The first Japanese scientist to win the Nobel Prize in Physiology or Medicine, he went on to discover how memories are stored, advancing understanding of how the brain works.

nytimes.com

Weshalb tragen diese ⚕️ Experten keine FFP Atemschutzmasken aus Eigenverantwortung? Glauben sie wirklich sie seien immun gegen SARSCoV2? Was haben diese ⚕️Eliten zur Behandlung von Covid-19, die das gemeine Volk nicht hat⁉️ Ich habe Fragen- ⚠️

⚕️Elite
Nationale Akademie der Wissenschaften Leopoldina@leopoldina.org · last wk.

Mathias H. Tschöp ist seit 2025 Präsident der @lmu.de und seit 2013 Mitglied der Nationalen Akademie der Wissenschaften Leopoldina. Mehr zu seiner Forschung: www.leopoldina.org/newsroom/nac...

Taiwan's COVID-19 wave is expected to peak in early August. 🔹 Weekly outpatient and ER visits are forecast to reach 51,000 before easing in September 🔹 Last week, outpatient and ER visits jumped 117.4% to 10,605 🔹 The youngest severe COVID-19 case this year is an unvaccinated 7-month-old girl

COVID-19 wave in Taiwan expected to peak in early August: CDC - Focus Taiwan

Taiwan's Centers for Disease Control (CDC) said Tuesday that the current COVID-19 wave in the country is expected to peak in early August, earlier than previously forecast.

focustaiwan.tw

The Congo’s ongoing Ebola outbreak has reached 3,262 confirmed cases and 1,437 deaths, approaching the country's record 2018–2020 toll (3,400+ cases, 2,200+ deaths) Historically, only the 2014–2016 West Africa outbreak was worse, causing 28,000 cases and over 11,000 deaths.

Ebola cases in Congo top 3,200, nearing record of the country's worst outbreak

The Ebola outbreak in eastern Congo has surpassed 3,200 cases

abcnews.com

DAK-Analyse der Krankenstand im ersten Halbjahr 2026 lag bei 5,3 % Im Vergleich zum Vorjahr sank der Krankenstand um 0,1 % 🤡 So lag dieser im ersten Halbjahr 2025 bei 5,4 Prozent🙄